Interstitial Lymphocytic Lung Disease
1 clinical trials · Condition
◉ Watch Interstitial Lymphocytic Lung Disease
| Record | Firm | Date |
|---|---|---|
| Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies. (NCT04572620) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-09-07 |
Track Interstitial Lymphocytic Lung Disease automatically
Every clearance here is in the API, with alerts when new ones post.